Fifth disease: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) |
|||
| Line 30: | Line 30: | ||
==Treatment== | ==Treatment== | ||
[[Fifth disease medical therapy|Medical Therapy]] | [[Fifth disease primary prevention|Primary | [[Fifth disease medical therapy|Medical Therapy]] | [[Fifth disease primary prevention|Primary Prevention]] | [[Fifth disease cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Fifth disease future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | ==Case Studies== | ||
Revision as of 14:48, 6 December 2012
For patient information click here
|
Fifth disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Fifth disease On the Web |
|
American Roentgen Ray Society Images of Fifth disease |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Synonyms and keywords: Human parvovirus 19; erythema infectiosum
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Fifth Disease from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Primary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies